Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (22)

2022

  1. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

    The Lancet Neurology, Vol. 21, Núm. 10, pp. 899-910

  2. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

  3. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

  2. Sex-specific protective effects of APOE ε2 on cognitive performance

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 76, Núm. 1, pp. 41-49

2020

  1. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

    Scientific Reports, Vol. 10, Núm. 1

  2. The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Subclinical cervico-cerebral stenosis and middle cerebral artery pulsatility index as predictors of long-term incident cognitive impairment

    Atherosclerosis, Vol. 312, pp. 104-109

  3. Third Ventricle Width Assessed by Transcranial Sonography as Predictor of Long-Term Cognitive Impairment

    Journal of Alzheimer's Disease, Vol. 73, Núm. 2, pp. 741-749

2019

  1. Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 394, Núm. 10193, pp. 139-147

  2. Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: Insights from the randomized URICO-ICTUS Trial

    Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 171-177

2014

  1. Diffusion tensor imaging, intracranial vascular resistance and cognition in middle-aged asymptomatic subjects

    Cerebrovascular Diseases, Vol. 38, Núm. 1, pp. 24-30

  2. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial

    The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460

  3. Thalamic diffusion differences related to cognitive function in white matter lesions

    Neurobiology of Aging, Vol. 35, Núm. 5, pp. 1103-1110

  4. Tract-specific fractional anisotropy predicts cognitive outcome in a community sample of middle-aged participants with white matter lesions

    Journal of Cerebral Blood Flow and Metabolism, Vol. 34, Núm. 5, pp. 861-869

2013

  1. Asymptomatic cervicocerebral atherosclerosis, intracranial vascular resistance and cognition: The AsIA-Neuropsychology Study

    Atherosclerosis, Vol. 230, Núm. 2, pp. 330-335

  2. Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors

    Cerebrovascular Diseases, Vol. 36, Núm. 2, pp. 98-105

2012

  1. Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants

    Journal of the International Neuropsychological Society, Vol. 18, Núm. 5, pp. 874-885

  2. Structural brain changes and cognition in relation to markers of vascular dysfunction

    Neurobiology of Aging, Vol. 33, Núm. 5, pp. 1003.e9-1003.e17

  3. Structural brain changes and cognition in relation to markers of vascular dysfunction.

    Neurobiology of aging, Vol. 33, Núm. 5